Overview

Pharmacokinetics and Pharmacodynamics of Oral Transmucosal Dexmedetomidine.

Status:
Completed
Trial end date:
2019-07-01
Target enrollment:
Participant gender:
Summary
Oral trans-mucosal administration is relatively easy and convenient, it also reduces first pass metabolism and has been used successfully for fentanyl, ketamine, and midazolam premedication.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Assiut University
Treatments:
Dexmedetomidine